Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eisai Inc.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants must have met all of the following criteria to be included in this study:
1. Diagnosis of epilepsy
2. Initiated treatment with Fycompa at any time after 01 Jan 2014
3. Provided written informed consent by the participant or the participant's legally authorized representative signed for the use of medical records (if required by an Institutional Review Board \[IRB\] or Independent Ethics Committee \[IEC\], or by regulatory authorities).
You may not be if
Not applicable
Clareo Health | Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
